PubMed Health⌕ Search

PubMed · 2668997

Electroconvulsive therapy for depression in general psychiatric practice.

Abstract

This paper identifies areas of consensus about the use of electroconvulsive therapy (ECT) for depression and some of the important points of disagreement which have implications for clinical practice and research. The clinical indications for ECT as a primary treatment of choice, a secondary treatment, and a maintenance or prophylactic treatment for depression are described. The commonly accepted outcome findings that ECT is highly effective are contrasted with more recent data indicating it may be quite ineffective when administered with a low-dose electric stimulus. The constituents of the treatment dosage are presented in the context of controversy surrounding the respective contributions of the electrical energy of the stimulus and the convulsions themselves to the overall therapeutic effectiveness. The points of consensus within the limited knowledge in this area are identified as the basis for the most appropriate approach to the design of clinical dosage protocols. It is concluded that ECT is an effective treatment for some of the severe presentations of depression. Its therapeutic effectiveness should not be compromised by efforts to minimize the side effects through excessive dosage reduction.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

B A Martin. 1989. Electroconvulsive therapy for depression in general psychiatric practice.. https://pubmed.ncbi.nlm.nih.gov/2668997/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Psychological morbidity and female urinary incontinence.

Female urinary incontinence is a common yet distressing condition. It affects women of all ages, but is especially common in the elderly. Its prevalence ranges from 15 to 55%, depending on age and population studied. Despite the ubiquity of female urinary incontinence, many incontinent women do not voice their suffering, and urinary incontinence has therefore been dubbed 'the silent epidemic'. The physical impact and social isolation associated with urinary incontinence lead to impairment of quality of life and psychological well-being. It is the aim of this review to discuss the epidemiology and psychological impact of urinary incontinence. The recognition and management of incontinence-related psychological morbidity are also explored.

Depressive Disorder↗

Vagus nerve stimulation therapy in depression and epilepsy: therapeutic parameter settings.

Vagus nerve stimulation (VNS) therapy is an effective adjunctive treatment for chronic or recurrent treatment-resistant depression in adults, and for pharmacoresistant epilepsy in adults and adolescents. VNS therapy is administered through an implanted pulse generator that delivers programmed electrical pulses through an implanted lead to the left vagus nerve. Programmable pulse parameters include output current, frequency, pulse width, and ON/OFF times. Within a range of typical values, individual patients respond best to different combinations of parameter settings. The physician must identify the optimum settings for each patient while balancing the goals of maximizing efficacy, minimizing side effects, and preserving battery life. Output current is gradually increased from 0.25 mA to the maximum tolerable level (maximum, 3.5 mA); typical therapeutic settings range from 1.0 to 1.5 mA. Greater output current is associated with increased side effects, including voice alteration, cough, a feeling of throat tightening, and dyspnea. Frequency is typically programmed at 20 Hz in depression and 30 Hz in epilepsy. Pulse width is typically 250 or 500 micros. The recommended initial ON time is 30 s, followed by 5 min OFF; OFF time > ON time is recommended. As with pharmacotherapy, VNS therapy must be adjusted in a gradual, systematic fashion to individualize therapy for each patient.

Depressive Disorder↗